Trademark: 79255122
Word
ABZORVE
Status
Registered
Status Code
700
Status Date
Tuesday, November 12, 2019
Serial Number
79255122
Registration Number
5905897
Registration Date
Tuesday, November 12, 2019
Mark Type
4000
Filing Date
Wednesday, February 27, 2019
Published for Opposition
Tuesday, August 27, 2019

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Trademark Events
Jul 19, 2023
Change Of Name/Address Rec'd From Ib
Aug 1, 2022
Teas Change Of Correspondence Received
Aug 1, 2022
Teas Change Of Domestic Representatives Address
Aug 1, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 1, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 20, 2020
Final Decision Transaction Processed By Ib
Mar 3, 2020
Final Disposition Notice Sent To Ib
Mar 3, 2020
Final Disposition Processed
Feb 12, 2020
Final Disposition Notice Created, To Be Sent To Ib
Nov 12, 2019
Registered-Principal Register
Aug 27, 2019
Official Gazette Publication Confirmation E-Mailed
Aug 27, 2019
Published For Opposition
Aug 23, 2019
Notification Processed By Ib
Aug 7, 2019
Notification Of Possible Opposition Sent To Ib
Aug 7, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 7, 2019
Notification Of Notice Of Publication E-Mailed
Jul 23, 2019
Approved For Pub - Principal Register
Jul 18, 2019
Teas/Email Correspondence Entered
Jul 18, 2019
Correspondence Received In Law Office
Jul 18, 2019
Assigned To Lie
Jul 12, 2019
Teas Response To Office Action Received
May 17, 2019
Refusal Processed By Ib
Apr 30, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Apr 30, 2019
Refusal Processed By Mpu
Apr 9, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Apr 8, 2019
Non-Final Action Written
Apr 3, 2019
Assigned To Examiner
Apr 2, 2019
Application Filing Receipt Mailed
Mar 27, 2019
New Application Office Supplied Data Entered
Mar 21, 2019
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24